<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53745">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02036931</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.GH20.13</org_study_id>
    <nct_id>NCT02036931</nct_id>
  </id_info>
  <brief_title>A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System</brief_title>
  <acronym>G7 Early Eval</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Biomet, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biomet, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to evaluate the clinical and radiographic performance
      of the G7 Acetabular Cup System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary purpose of this study is to evaluate the clinical and radiographic performance
      of the G7 Acetabular Cup System in both primary and revision procedures, report safety and
      survivorship, and document instrument ease of use.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>2 Year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxford Hip Score</measure>
    <time_frame>1, 2, 5 Year post-operative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Evaluation</measure>
    <time_frame>1, 2, and 5 Year post-opertive</time_frame>
    <safety_issue>No</safety_issue>
    <description>Stability, Radiolucencies (mm), Angle of Inclination (degree)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survivorship</measure>
    <time_frame>7 and 10 Year post-operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>3-month, 1-year, 2 year, 5-year post-operative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">315</enrollment>
  <condition>Noninflammatory Degenerative Joint Disease</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Metal on Polyethylene articulation</arm_group_label>
    <description>G7 cup with Metal on Polyethylene articulation (MOP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ceramic on Polyethylene articulation</arm_group_label>
    <description>G7 cup with Ceramic on Polyethylene articulation (COP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ceramic on Ceramic articulation</arm_group_label>
    <description>G7 cup with Ceramic on Ceramic articulation (COC)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Metal on Polyethylene articulation</intervention_name>
    <description>G7 Acetabular Cup System with Metal head on Polyethylene liner articulation (MOP)</description>
    <arm_group_label>Metal on Polyethylene articulation</arm_group_label>
    <other_name>MOP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ceramic on Polyethylene articulation</intervention_name>
    <description>G7 Acetabular Cup System with Ceramic head on Polyethylene liner articulation (COP)</description>
    <arm_group_label>Ceramic on Polyethylene articulation</arm_group_label>
    <other_name>COP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ceramic on Ceramic articulation</intervention_name>
    <description>G7 Acetabular Cup System with Ceramic head on Ceramic linear articulation (COC) - Outside the United States ONLY</description>
    <arm_group_label>Ceramic on Ceramic articulation</arm_group_label>
    <other_name>COC</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Noninflammatory degenerative joint disease including osteoarthritis and avascular
             necrosis

          -  Rheumatoid arthritis

          -  Correction of functional deformity

          -  Treatment of non-union, femoral neck fracture, and trochanteric fractures of the
             proximal femur with head involvement, unmanageable by other techniques

          -  Revision procedures where other treatment or devices have failed

          -  18 years of age or older

          -  Subjects willing to return for follow-up evaluations

        Exclusion Criteria:

          -  Infection, sepsis and osteomyelitis

          -  Subjects unable to cooperate with and complete the study

          -  Neurological conditions affecting movement

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Russell Schenck, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Biomet, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Orthopedic Specialists</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joint Replacement Surgeons of Indiana</name>
      <address>
        <city>Mooresville</city>
        <state>Indiana</state>
        <zip>46158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clermont-Ferrand Hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwestern Regional Orthopaedic Hospital</name>
      <address>
        <city>Limerick</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reinier de Groep</name>
      <address>
        <city>Delft</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital El Bierzo</name>
      <address>
        <city>Ponferrada</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
    <country>France</country>
    <country>Ireland</country>
    <country>Netherlands</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>March 19, 2014</lastchanged_date>
  <firstreceived_date>January 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Joint</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Avascular Necrosis</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
